/Sponsor / Executive Profile

Alexander Arrow

Executive

Aggregate Capital Deployment Matrix

Professional Biography

Alexander K. Arrow has been our director since March 27, 2019. He has been the Chief Financial Officer of Protagenic Therapeutics, Inc. since November 2015.

Total Capital Deployed

$136,250,000

Active / Searching Capital:
-

Transaction Volume

3 Transactions

Time-to-Liquidity (Months)

-

Merger Completion Rate

0.0%

Professional Network Intelligence

Frequent Associates

Top Sectors

  • Financial Technology1 Deals

Syndicate Deal History

TickerCompanyStatusTrustPriceWarrantIPO DateTime LeftDeal ValueSectorBookrunner
EUDA
8i Acquisition 2 Corp.
announced
86.3M
$10.00
1/2May 2021--GeneralGuggenheim Securities, LLC
EQOS
8i Enterprises Acquisition Corp
closed
-
-
-Nov 2020Done-Financial Technology
-
JFK
8i Enterprises Acquisition Corp
closed
50.0M
$10.00
1/2Feb 2019Done-GeneralChardan Capital Markets, LLC